SCHEMBL15868131

SCHEMBL15868131

CCOC(=O)c1cc(-c2cc(-c3nccs3)ccc2C)n(C)n1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FAAH O00519 2/20 0.43
▸ MMP13 P45452 2/20 0.43
▸ MMP2 P08253 1/20 0.43
▸ MMP14 P50281 1/20 0.43
▸ PTGDR2 Q9Y5Y4 1/20 0.41
▸ PDE5A O76074 1/20 0.41
▸ NPC1 O15118 2/20 0.38
▸ RAB9A P51151 2/20 0.38
▸ KDM4E B2RXH2 1/20 0.38
▸ SMN1; SMN2 Q16637 1/20 0.38
▸ ABL1 P00519 1/20 0.38
▸ CA9 Q16790 1/20 0.38
▸ MAPK14 Q16539 1/20 0.37
▸ SMO Q99835 1/20 0.37
▸ PORCN Q9H237 1/20 0.37
▸ NR1H2 P55055 1/20 0.37
▸ CHRNA7 P36544 2/20 0.37
▸ POLB P06746 1/20 0.36
▸ MAPT P10636 1/20 0.36
▸ PKM P14618 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15884137 0.92 FAAH (0.43) FAAHMMP13MMP2MMP14PTGDR2
SCHEMBL15868139 0.90 FAAH (0.42) FAAHMMP13MMP2MMP14PTGDR2
SCHEMBL15868126 0.89 PTGDR2 (0.44) FAAHMMP13MMP2MMP14PTGDR2
SCHEMBL15868125 0.86 PTGDR2 (0.42) PTGDR2PDE5AKDM4EABL1MAPK14
SCHEMBL15868158 0.85 FAAH (0.51) FAAHMMP13MMP2MMP14PTGDR2
SCHEMBL15873637 0.82 TP53 (0.46) NPC1RAB9AKDM4ESMN1; SMN2MAPK14
SCHEMBL15868129 0.82 FAAH (0.47) FAAHMMP13MMP2MMP14CA9
SCHEMBL15884057 0.81 PTGDR2 (0.43) PTGDR2PDE5ANPC1ABL1MAPK14
SCHEMBL15868154 0.80 FAAH (0.43) FAAHMMP13MMP2MMP14NPC1
SCHEMBL15868168 0.79 FAAH (0.45) FAAHMMP13MMP2MMP14NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9206136-B2 Pyrazolyl-based carboxamides I Grünenthal GmbH (DE) 2015-12-08 — — US disclosed
US-9206136-B2 Pyrazolyl-based carboxamides I Grünenthal GmbH (DE) 2015-12-08 — — US disclosed
WO-2014108337-A1 PYRAZOLYL-BASED CARBOXAMIDES I AS CRAC CHANNEL INHIBITORS Grünenthal GmbH (DE) 2014-07-17 — — WO disclosed
US-20140194443-A1 Pyrazolyl-Based Carboxamides I Grünenthal GmbH (DE) 2014-07-10 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140194443-A1 Pyrazolyl-Based Carboxamides I AADAC, HDAC3, NLRP3 FAAH 1038/4885MMP13 3001/4885MMP2 4450/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback